Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy

Since 1990, the primary criteria used for assessing response to therapy in high-grade gliomas were those developed by Macdonald and colleagues, which incorporated 2-dimensional area measurements of contrast-enhancing tumor regions, corticosteroid dosing, and clinical assessment to arrive at a design...

Descripción completa

Detalles Bibliográficos
Autores principales: Chinot, Olivier L., Macdonald, David R., Abrey, Lauren E., Zahlmann, Gudrun, Kerloëguen, Yannick, Cloughesy, Timothy F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Current Science Inc. 2013
Materias:
Neuro-Oncology (LE Abrey, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631110/
https://www.ncbi.nlm.nih.gov/pubmed/23529375
http://dx.doi.org/10.1007/s11910-013-0347-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631110/
https://www.ncbi.nlm.nih.gov/pubmed/23529375
http://dx.doi.org/10.1007/s11910-013-0347-2

Ejemplares similares